Physician

John James Rommel, MD

According to 2025 Medicare claims, John Rommel, MD (NPI: 1205061678) practices advanced heart failure and transplant cardiology in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (NPI: 1649865791; TIN: 581728803) and primary practice location at 28401-7338. Rommel is affiliated with the Physician Quality Partners, LLC (ACO ID: A2778) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rommel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 793 traditional Medicare patients, billed 2,737 HCPCS/CPT codes, and received $161,248 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,756 prescription claims across 358 beneficiaries totaling $1,371,835 in drug costs, led by Vyndamax (Tafamidis). 2023 DME data shows 59 claims. Open Payments data shows 51 records totaling $108,812. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $20,861 to $1,371,835. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,134 and ending at $30,838.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$101K$203K2016 Medicare payment: $47,084 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $166,394 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $202,983 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $198,636 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $193,622 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $186,637 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $175,300 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $188,526 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $161,248 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016215862$47,084
20177723,261$166,394
20188093,210$202,983
20198013,141$198,636
20207042,922$193,622
20217222,945$186,637
20221,0122,794$175,300
20239332,701$188,526
20247932,737$161,248

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$964K$1.9M2015 Drug cost: $20,861 (USD; Tot_Drug_Cst)2016 Drug cost: $20,350 (USD; Tot_Drug_Cst)2017 Drug cost: $71,666 (USD; Tot_Drug_Cst)2018 Drug cost: $160,198 (USD; Tot_Drug_Cst)2019 Drug cost: $209,913 (USD; Tot_Drug_Cst)2020 Drug cost: $765,762 (USD; Tot_Drug_Cst)2021 Drug cost: $1,927,980 (USD; Tot_Drug_Cst)2022 Drug cost: $1,303,403 (USD; Tot_Drug_Cst)2023 Drug cost: $685,664 (USD; Tot_Drug_Cst)2024 Drug cost: $1,371,835 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201556368$20,861
201689310$20,350
20171631,094$71,666
20182061,773$160,198
20192621,805$209,913
20203052,630$765,762
20213643,246$1,927,980
20223713,246$1,303,403
20233452,700$685,664
20243582,756$1,371,835

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$30K$59K2017 Medicare payment: $31,320 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $24,943 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $32,558 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $7,866 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,948 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $59,287 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $30,270 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R16$31,320
2018N/R351$24,943
2019N/R85$32,558
2020N/R147$7,866
2021N/R145$6,948
2022N/R147$59,287
2023N/R59$30,270
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more123211$123
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more146230$89
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes139250$88
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function337338$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's187385$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis301,140$817,697
EntrestoSacubitril/Valsartan1187,696$153,962
FarxigaDapagliflozin Propanediol1126,614$120,104
JardianceEmpagliflozin623,900$74,194
EliquisApixaban443,018$56,147

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$54,240ABIOMED
Research PaymentsReported research-related payment or transfer-of-value amount.9$54,572Medtronic, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John James Rommel, MD?

Tedicare shows public-source Medicare data for John James Rommel, MD (NPI 1205061678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John James Rommel, MD have ACO affiliation data?

John James Rommel, MD is shown with ACO affiliation data for Physician Quality Partners, LLC (MSSP, ACO ID A2778) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to John James Rommel, MD?

John James Rommel, MD is linked to NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (billing NPI 1649865791) in the available physician profile data.

Does John James Rommel, MD have Open Payments data?

John James Rommel, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.